Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, Two Forms of Neuropathic Pruritus
DOI:
https://doi.org/10.2340/00015555-2472Keywords:
pruritus, cost, capsaicin, cost-benefit analysisAbstract
In brachioradial pruritus and notalgia paraesthetica, the 8% capsaicin patch is a novel and effective, but cost-intense, therapy. Routine data for 44 patients were collected 6 months retrospectively and prospectively to first patch application. The cost to health insurance and the patient, and patient-reported outcomes were analysed (visual analogue scale, numerical rating scale, verbal rating scale for pruritus symptoms, Dermatological Life Quality Index, and Patient Benefit Index). Mean inpatient treatment costs were reduced by ?212.31, and mean outpatient treatment and medication costs by ?100.74 per patient (p.p.). However, these reductions did not offset the high cost of the patch itself (?767.02 p.p.); thus the total cost to health insurance increased by ?453.97 p.p. (p≤0.01). The additional costs of therapy to the patient decreased by ?441.06, thus the overall cost p.p. remained approximately the same (?3,306.03 vs. ?3,318.94). Capsaicin patch therapy resulted in reduced pruritus, improved quality of life and greater patient benefit, thus long-term cost-efficiency analyses are necessary.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Sabine Steinke, Mandy Gutknecht, Claudia Zeidler, Anette Maria Dieckhöfer, Olga Herrlein, Hannah Lüling, Sonja Ständer, Matthias Augustin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.